NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Star Health's AA+ Issuer Rating Reaffirmed by Care Ratings with Stable Outlook
Care Ratings Limited has reaffirmed the credit ratings for Star Health and Allied Insurance Company Limited, signaling continued financial stability. The company's issuer rating remains at 'AA+' with a Stable outlook, while its subordinate debt rating is maintained at 'AA' with a Stable outlook. This reaffirmation reflects the rating agency's confidence in the insurer's creditworthiness and ability to service its debt obligations. The disclosure was made in compliance with SEBI Listing Obligations and Disclosure Requirements.
முக்கிய அம்சங்கள்
Care Ratings reaffirmed the Issuer Rating at AA+ with a Stable outlook.The rating for the company's subordinate debt was reaffirmed at AA with a Stable outlook.The announcement confirms compliance with SEBI Regulations 30 and 55.Ratings reaffirmation indicates a consistent credit profile and financial health for the insurer.
👀 கவனிக்க வேண்டியவை
Investors should take this as a positive sign of the company's credit strength and financial stability. No immediate portfolio changes are necessary as the ratings remain unchanged from previous levels.
Blue Star Shareholders Approve Re-appointment of MD B Thiagarajan and New Director Appointments
Blue Star Limited has announced the successful passage of three key leadership resolutions via postal ballot as of March 31, 2026. Shareholders approved the re-appointment of Mr. B Thiagarajan as Managing Director through May 2027, ensuring leadership continuity. Additionally, Mr. Mohit Sud was appointed as Executive Director for the Unitary Cooling Products Group for five years, and Mr. M S Unnikrishnan joined as an Independent Director. These moves strengthen the board and management team for the upcoming fiscal years.
முக்கிய அம்சங்கள்
Re-appointment of B Thiagarajan as Managing Director approved from April 1, 2026, to May 24, 2027Mohit Sud appointed as Executive Director - Unitary Cooling Products Group for a 5-year termM S Unnikrishnan appointed as Independent Director for a 5-year term effective January 29, 2026Total of 1,09,412 shareholders were eligible to vote as of the cut-off dateAll resolutions were passed with the requisite majority via remote e-voting
👀 கவனிக்க வேண்டியவை
Investors should take confidence in the leadership continuity provided by the MD's re-appointment. Monitor the performance of the Unitary Cooling Products segment under the new Executive Director's leadership.
Star Cement Seeks Reclassification of Chamaria Group (6.05% Stake) to Public Category
Star Cement Limited has applied to the NSE and BSE for the reclassification of 29 members of the Chamaria Group from the 'Promoter' to 'Public' category. This group collectively holds 2,44,60,037 equity shares, representing approximately 6.052% of the company's total share capital as of December 31, 2025. The Board of Directors approved this move on February 6, 2026, confirming the group meets SEBI's regulatory criteria for reclassification. Additionally, the company recently declared a 100% interim dividend of Re. 1 per share.
முக்கிய அம்சங்கள்
Application filed to reclassify 29 members of the Chamaria Group to the Public category.The group holds 24,460,037 shares, accounting for 6.052% of the total equity.Application for no-objection was submitted to stock exchanges on February 10, 2026.Board declared a second interim dividend of 100% (Re. 1 per share) for FY 2025-26.The reclassification is pursuant to Regulation 31A of SEBI LODR Regulations.
👀 கவனிக்க வேண்டியவை
Investors should monitor the change in shareholding structure as it technically increases the public float, though it does not change the company's operational fundamentals. No immediate action is required as this is a regulatory classification update.
Five-Star Business Finance Allots 3.1 Lakh Equity Shares to Promoters at INR 770/Share
Five-Star Business Finance has converted 3,10,000 share warrants into equity shares for its top leadership, including the CMD and CFO. The conversion was executed at a price of INR 770 per share, resulting in a total capital infusion of approximately INR 23.87 crore. Following this allotment, the promoter group's stake has marginally increased from 18.41% to 18.48% on a fully diluted basis. This move demonstrates strong commitment from the leadership team as they exercise their options well within the stipulated 18-month window.
முக்கிய அம்சங்கள்
Allotment of 3,10,000 equity shares at a conversion price of INR 770 per shareTotal capital raised through this conversion amounts to approximately INR 23.87 crorePromoter and CMD Lakshmipathy Deenadayalan acquired 2,60,000 shares, increasing his individual holdingJoint MD & CFO Srikanth Gopalakrishnan converted 50,000 warrants into equityTotal paid-up share capital increased to 29,48,76,168 equity shares
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive signal as the top management is increasing their stake at a significant premium, reflecting long-term confidence in the company's business model. No immediate action is required, but it reinforces the stability of the leadership's interest.
Strides Pharma to Acquire Sandoz Generic Brands in Africa for USD 12 Million
Strides Pharma Science, through its subsidiary, has entered into an agreement to acquire and in-license a portfolio of branded generic products from Sandoz across Sub-Saharan Africa. The deal involves an upfront payment of USD 12 million plus variable royalty payments based on future sales. This strategic move targets four key markets—Nigeria, Kenya, Ghana, and Western Sahara—and is expected to position Strides among the top five pharmaceutical companies in the region. The transaction is slated for completion by the end of September 2026.
முக்கிய அம்சங்கள்
Upfront consideration of USD 12 million for acquisition and in-licensing of Sandoz brands.Targets high-growth Sub-Saharan African markets including Nigeria, Kenya, Ghana, and Western Sahara.Expected to elevate Strides to a top 5 pharmaceutical player in the SSA region by sales volume.Portfolio includes established brands in anti-infective, cardiovascular, and dermatology segments.Transaction includes a corporate guarantee from a Singapore subsidiary to secure payment obligations.
👀 கவனிக்க வேண்டியவை
Investors should monitor the integration of these brands as it significantly strengthens Strides' footprint in the African market. The deal is a positive step toward scaling their international branded generics business, though the full financial impact will only be visible after Q2 FY27.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Five-Star Business Finance Board Approves INR 5,000 Crore Fundraise via NCDs
The Board of Directors of Five-Star Business Finance has approved a significant fundraising limit of up to INR 5,000 Crores. This capital will be raised through the issuance of Non-Convertible Debentures (NCDs) via private placement in one or more tranches. The move is intended to bolster the company's capital base and support its ongoing lending operations. Specific details regarding interest rates and tenures will be disclosed at the time of each allotment.
முக்கிய அம்சங்கள்
Board approved a fundraising limit of up to INR 5,000 Crores through NCDs.Issuance will be conducted via private placement in one or more tranches or series.The NCDs are proposed to be listed on stock exchanges to be named at allotment.The board meeting concluded on March 17, 2026, with immediate approval of the limits.
👀 கவனிக்க வேண்டியவை
Investors should monitor the coupon rates of future tranches to assess the company's cost of funds and its impact on net interest margins. The large fundraising limit indicates a strong growth outlook for the company's loan portfolio.
Prostarm Info Systems Declared L-1 Bidder for INR 90.44 Crore WBMSC Contract
Prostarm Info Systems Limited has been declared the L-1 bidder for a significant domestic contract from West Bengal Medical Services Corporation (WBMSC) worth INR 90.44 Crores. The project involves the supply, installation, and commissioning of 6 KVA online UPS systems and batteries across 3,439 healthcare facilities throughout West Bengal. The contract is funded under the XV Finance Commission and is expected to be completed within a 180-day timeframe. This order represents a substantial boost to the company's order book and revenue visibility for the next two quarters.
முக்கிய அம்சங்கள்
Declared L-1 bidder for a contract valued at INR 90.44 Crores from WBMSC KolkataScope covers 3,439 locations including 3,000 Sub Centers and 439 Urban Health CentersExecution timeline is strictly set at 180 days for supply and commissioningProject involves 6 KVA single-phase input/output online UPS systems including batteries
👀 கவனிக்க வேண்டியவை
Investors should monitor the formal award of the contract and the company's execution progress over the next six months, as this large order could significantly impact short-term earnings.
Prostarm Secures INR 6.71 Cr Order from SAIL for 2 MW Roof Top Solar Project
Prostarm Info Systems Limited has received a Letter of Acceptance (LOA) from Steel Authority of India Limited (SAIL) for a solar infrastructure project. The contract involves the supply, installation, and commissioning of a 2 MW (AC) Roof Top Solar PV System at various plant buildings. Valued at INR 6.71 Crores, the project is slated for completion within a 12-month timeframe. This domestic order from a major PSU enhances the company's credentials in the renewable energy sector.
முக்கிய அம்சங்கள்
Received a Letter of Acceptance from Steel Authority of India Limited (SAIL) worth INR 6.71 CroresScope includes supply, installation, and commissioning of a 2 MW (AC) Roof Top Solar PV SystemProject execution period is defined as 12 monthsThe order is domestic and was secured in the normal course of business
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development that strengthens the order book and validates the company's technical capabilities with a major PSU client. Monitor the execution progress over the next 12 months to ensure timely revenue recognition.
Blue Star Launches 125 New AC Models for 2026, Targets 1.8M Unit Capacity
Blue Star has unveiled a comprehensive range of 125 new Room Air Conditioner models for the 2026 summer season, all compliant with the latest BEE energy standards. The company is scaling its manufacturing capacity from 1.4 million to 1.8 million units to meet a projected industry demand of 30 million units by FY30. Key product innovations include 'Super Energy-Efficient ACs' with an ISEER of 6.25 and heavy-duty models capable of cooling at 56°C. The expansion strategically targets high-growth Tier 3-5 markets and includes a robust range of commercial refrigeration solutions for sectors like healthcare and quick commerce.
முக்கிய அம்சங்கள்
Launched 125 new Room AC models including the premium 'Iconia' range and 'Super Energy-Efficient' units with 6.25 ISEER.Manufacturing capacity currently at 1.4 million units, with scalability up to 1.8 million units across three plants.Distribution network expanded to 900 towns with over 10,000 retail outlets and 2,100 service partners.Heavy-duty ACs designed to maintain full cooling capacity at 43°C and operate in temperatures up to 56°C.Strategic focus on Tier 3, 4, and 5 markets to capture first-time buyers and replacement demand.
👀 கவனிக்க வேண்டியவை
Investors should monitor market share gains in under-penetrated Tier 3-5 cities and the successful ramp-up of the Sri City facility. The stock remains a strong play on India's rising cooling demand and energy efficiency trends.
Blue Star Seeks Shareholder Approval for Key Leadership Appointments and Re-appointments
Blue Star Limited has issued a postal ballot notice to seek shareholder approval for three significant board positions. The company proposes the re-appointment of Mr. B Thiagarajan as Managing Director until May 2027 and the appointment of Mr. Mohit Sud as Executive Director for the Unitary Cooling Products Group for a five-year term. Additionally, Mr. M S Unnikrishnan is proposed as an Independent Director for a five-year term effective January 2026. These appointments are intended to ensure leadership continuity and functional expertise in core business segments.
முக்கிய அம்சங்கள்
Re-appointment of Mr. B Thiagarajan as Managing Director from April 1, 2026, to May 24, 2027.Appointment of Mr. Mohit Sud as Executive Director for a 5-year term starting April 1, 2026.Appointment of Mr. M S Unnikrishnan as Independent Director for a 5-year term from Jan 29, 2026, to Jan 28, 2031.Remote e-voting period scheduled from March 2, 2026, to March 31, 2026.Final results of the postal ballot to be declared on or before April 2, 2026.
👀 கவனிக்க வேண்டியவை
Investors should note the leadership continuity in the Managing Director role and the addition of specialized leadership for the cooling products group. No immediate action is required as these are standard governance procedures to formalize management structure.
Prostarm Secures INR 13.43 Crore Solar Project from South Eastern Railway
Prostarm Info Systems Limited has received a Letter of Acceptance from South Eastern Railway for a solar power plant project. The contract is valued at INR 13.43 Crores and involves the supply, installation, and erection of the plant at SRC Jurisdiction (Phase 2). The project is scheduled for completion within 12 months and includes a 5-year comprehensive maintenance contract. This order strengthens the company's order book and highlights its growing footprint in the renewable energy sector.
முக்கிய அம்சங்கள்
Awarded a contract worth INR 13.43 Crores by South Eastern RailwayScope includes supply, installation, and erection of a solar power plantProject execution timeline is 12 months from the date of LOAIncludes a 5-year Comprehensive Maintenance Contract (CMC) post-installationThe contract was secured in the normal course of business for Phase 2 of the SRC Jurisdiction
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for revenue visibility and track the company's execution efficiency over the 12-month period. The 5-year maintenance component provides a small but steady stream of recurring service income.
Star Cement Subsidiary Starts Commercial Production at 2.0 MTPA Grinding Unit in Assam
Star Cement Limited's subsidiary, Star Cement North East Limited, has successfully commenced commercial production at its new grinding unit in Cachar, Assam, as of February 20, 2026. The new facility adds a substantial 2.0 MTPA (Million Tonnes Per Annum) to the company's existing production capacity. This expansion is strategically located to serve the high-demand Northeast Indian market. The operationalization of this unit is expected to drive volume growth and enhance the company's regional market share in the near term.
முக்கிய அம்சங்கள்
Commencement of commercial production at a new 2.0 MTPA grinding unit in Cachar, Assam.The project was executed through the subsidiary company, Star Cement North East Limited.Operations officially began on February 20, 2026, following successful setup.The expansion significantly boosts the company's total cement grinding capacity in its core Northeast market.
👀 கவனிக்க வேண்டியவை
Investors should consider this a positive development for long-term growth as it increases production capacity by 2.0 MTPA. Monitor the next few quarterly results to see the impact of this new capacity on revenue and EBITDA margins.
IndoStar Q3 PAT at ₹8.25 Cr; 9M Profit Surges to ₹554 Cr on NHFPL Divestment Gain
IndoStar Capital Finance reported a standalone Profit After Tax (PAT) of ₹8.25 crore for Q3 FY26, down from ₹11.41 crore in the previous year's corresponding quarter. The nine-month (9M FY26) PAT reached a significant ₹554.16 crore, primarily due to a one-time exceptional gain of ₹1,175.95 crore from the sale of its subsidiary, Niwas Housing Finance. Total revenue from operations for the quarter stood at ₹346.33 crore, showing a slight decline year-on-year. The company also accounted for a ₹4.8 crore impact on employee expenses following the notification of new Government Labour Codes.
முக்கிய அம்சங்கள்
Standalone PAT for Q3 FY26 stood at ₹8.25 crore compared to ₹11.41 crore in Q3 FY25.Exceptional gain of ₹1,175.95 crore recorded in 9M FY26 from the divestment of Niwas Housing Finance (NHFPL).Finance costs decreased to ₹137.13 crore in Q3 FY26 from ₹192.98 crore in the same quarter last year.Impairment on financial instruments rose to ₹76.92 crore in Q3 FY26 from ₹47.94 crore YoY.Stressed loans with an aggregate principal of ₹343.66 crore were transferred to ARCs during the nine-month period.
👀 கவனிக்க வேண்டியவை
Investors should monitor how the company deploys the substantial capital gains from the NHFPL sale to drive growth in its core lending segments. While operational profitability remains modest, the reduction in finance costs and a cleaner balance sheet post-ARC transfers are positive signs for long-term stability.
Prostarm Q3 FY26 Revenue Jumps 110% to ₹161 Cr; Order Book Robust at ₹946 Cr
Prostarm Info Systems reported a massive 110% YoY revenue growth in Q3 FY26, reaching INR 161 crores, driven by large-scale project executions. The company's order book stands at a robust INR 946 crores, providing strong visibility for the next 18 months. Profitability also saw a significant jump, with PAT rising 101% YoY to INR 15 crores. Additionally, the company has become effectively net debt-free and is nearing the commissioning of a 1.2 GW BESS facility in Jhajjar.
முக்கிய அம்சங்கள்
Q3 FY26 revenue grew 110% YoY to ₹161 crores, with PAT increasing 101% to ₹15 crores.Current order book stands at ₹946 crores across 91 projects, with an additional ₹775 crores in the bid pipeline.Long-term debt reduced to ₹1.5 crores, making the company effectively net debt-free.New 1.2 GW BESS manufacturing facility in Jhajjar is expected to be operational by Q4 FY26.Management guides for 20-25% revenue growth for the full year FY26.
👀 கவனிக்க வேண்டியவை
Investors should monitor the commissioning of the Jhajjar BESS facility and the execution of the large order book, which represents over 3x the current 9M revenue. The stock remains attractive due to its net debt-free status and strong growth trajectory in the energy storage sector.
Strides Pharma Subsidiary Completes 100% Acquisition of Neviton Softech for ₹21.77 Cr
Strides Pharma's wholly-owned subsidiary, Arco Lab, has acquired the remaining 50% stake in Neviton Softech for approximately ₹21.77 crores (Euro 2 million). Neviton, which specializes in IT services and IoT-based engineering solutions, reported a turnover of ₹27.08 crores and a PAT of ₹4.26 crores for FY25. This acquisition consolidates Neviton as a step-down subsidiary, following a phased investment strategy that began in 2022. The move is strategically aimed at enhancing Strides' internal digitization and driving operational cost efficiencies.
முக்கிய அம்சங்கள்
Acquisition of the final 50% equity interest in Neviton Softech for a cash consideration of ~₹21.77 crores.Neviton reported a steady financial performance with FY25 turnover of ₹27.08 crores and PAT of ₹4.26 crores.Target company specializes in high-tech areas including IoT devices and real-time data integration for engineering solutions.Strategic integration with Arco Lab is expected to yield significant cash savings and enable better group-wide digitization.
👀 கவனிக்க வேண்டியவை
This is a strategic bolt-on acquisition that strengthens the company's internal IT and digital capabilities at a reasonable valuation. Investors should monitor how these technological synergies contribute to long-term operational margin improvements.
IndoStar Q3 FY26: Disbursements Up 20% QoQ to ₹1,117 Cr; Vehicle Finance Leads Growth
IndoStar Capital Finance reported a 20% sequential growth in disbursements to ₹1,117 crores for Q3 FY26, driven primarily by the vehicle finance segment. The company's total AUM reached ₹7,692 crores, while Net Interest Income grew 16.1% year-on-year to ₹209 crores. Asset quality showed significant improvement, with delinquency levels in the 2025 cohort being 50% lower than previous years. Management is focusing on retail-led growth through used vehicle finance and Micro LAP, supported by a digital-first approach.
முக்கிய அம்சங்கள்
Total disbursements rose 20% QoQ to ₹1,117 crores, with vehicle finance contributing ₹1,087 crores.Net Interest Income (NII) increased by 16.1% YoY to ₹209 crores for the quarter.Asset quality improved significantly, with the 2025 cohort showing 50% lower delinquency levels than previous cohorts.Micro LAP segment AUM reached ₹128 crores with a collection efficiency near 100% and only 6 customers in 1+ DPD.Completed preferential allotment of 2.5 crore shares to promoters and Florintree upon warrant conversion.
👀 கவனிக்க வேண்டியவை
Investors should monitor the continued scale-up of the high-yield Micro LAP business and the impact of new leadership on vehicle finance margins. The improved asset quality of recent cohorts suggests a lower credit cost trajectory ahead.
Prostarm Info Systems Reports 9M FY26 Revenue of ₹2,813 Mn with ₹9,460 Mn Order Book
Prostarm Info Systems Limited showcased strong growth in its Q3 & 9M FY26 investor presentation, reporting an operating income of INR 2,813 Mn for the nine-month period. The company maintains a robust order book of INR 9,460 Mn, which is significantly higher than its annual revenue, providing high growth visibility. Key performance indicators remain healthy with an ROE of 27.82% and ROCE of 40.81%. Significant expansion is underway with a new 1.2 GWH BESS facility in Haryana expected to be operational by Q4-FY26 and a Gujarat unit in Q1-FY27.
முக்கிய அம்சங்கள்
Total order book stands at a significant INR 9,460 Mn as of February 2026Reported 9M-FY26 operating income of INR 2,813 Mn with an EBITDA margin of 12.55%Strong historical growth with a 3-year Revenue CAGR of 26.97% and PAT CAGR of 38.41%Expanding manufacturing footprint with a 1.2 GWH BESS unit in Haryana (Q4-FY26) and a new UPS unit in Gujarat (Q1-FY27)Secured major BESS orders from Adani Electricity, Bihar State Power, and KPTCL
👀 கவனிக்க வேண்டியவை
Investors should monitor the timely commissioning of the new BESS and UPS facilities, as these are critical for executing the massive ₹9,460 Mn order book. The company's entry into the high-growth BESS segment and its strong return ratios make it a key player to watch in the power conditioning space.
Melstar Reports Zero Revenue and ₹20.31 Lakh Loss in Q3 FY26; CFO Appointed
Melstar Information Technologies reported zero revenue for the quarter ended December 31, 2025, as it continues to struggle post-insolvency proceedings. The company recorded a net loss of ₹20.31 lakhs for the quarter, while the nine-month loss widened significantly to ₹118.41 lakhs from ₹29.95 lakhs in the previous year. Statutory auditors have issued a qualified opinion, raising concerns about the company's ability to continue as a 'going concern' given the lack of operations and reliance on future business licenses. Management has been restructured with the formal appointment of Raveendra Sangapu as CFO and Rose Mary Vase as an Independent Director.
முக்கிய அம்சங்கள்
Reported zero revenue from operations and zero other income for both Q3 FY26 and the nine-month period.Net loss for Q3 FY26 stood at ₹20.31 lakhs, compared to a loss of ₹23.07 lakhs in the same quarter last year.Nine-month (9M) net loss surged to ₹118.41 lakhs, a sharp increase from the ₹29.95 lakh loss reported in 9M FY25.Auditors issued a qualified conclusion citing the company's history of corporate insolvency and lack of current business activity.Board approved the appointment of Raveendra Sangapu as CFO and Rose Mary Vase as an Additional Independent Director.
👀 கவனிக்க வேண்டியவை
Investors should remain highly cautious as the company has no operational revenue and faces significant 'going concern' risks. The stock is speculative until there is clear evidence of business licenses being obtained and operations restarting.
Sanstar Q3 FY26 PAT Recovers to ₹137 Mn; Dhule Expansion to Commission in Feb 2026
Sanstar Limited reported a sequential recovery in Q3 FY26 with revenue of ₹2,018 million and a PAT of ₹137 million, following a volatile first half. EBITDA margins improved significantly to 8.9% in Q3 from a low of 0.7% in Q2, driven by higher plant utilization and better cost control. However, 9M FY26 performance remains subdued with revenue down 22.3% YoY to ₹5,679 million due to pricing pressure from Chinese exports in Southeast Asia. The company's major capacity expansion at Dhule is on track, with the native starch plant expected to commission by late February 2026.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue stood at ₹2,018 million, reflecting a 2.7% sequential growth over Q2.EBITDA recovered to ₹179 million in Q3 from ₹14 million in Q2, with margins reaching 8.9%.9M FY26 Revenue declined 22.3% YoY to ₹5,679 million, impacted by global pricing headwinds.Dhule expansion to 2,100 TPD is nearing completion, with the native starch unit set for Q4 FY26 commissioning.Exports contributed ₹644 million to Q3 revenue, serving 58 countries despite Chinese competition.
👀 கவனிக்க வேண்டியவை
Investors should focus on the successful commissioning and ramp-up of the Dhule expansion in Q4 FY26, which is critical for future volume growth. While sequential recovery is positive, the impact of Chinese export intensity on global starch realizations remains a key risk to monitor.
Sanstar Q3 FY26 Net Profit at ₹13.67 Cr; Sequential Recovery but 9M Profit Down 63% YoY
Sanstar Limited reported a strong sequential recovery in the quarter ended December 31, 2025, with net profit rising to ₹13.67 crore from a low of ₹0.63 crore in Q2 FY26. However, the year-on-year performance remains weak, with Q3 revenue declining 8.9% to ₹201.76 crore. For the nine-month period (9M FY26), net profit has fallen sharply to ₹13.96 crore compared to ₹38.28 crore in the previous year. On a positive note, finance costs have reduced significantly following the repayment of ₹100 crore in borrowings using IPO proceeds.
முக்கிய அம்சங்கள்
Net Profit for Q3 FY26 stood at ₹13.67 crore, recovering from ₹0.63 crore in the previous quarter.Revenue from operations for Q3 FY26 was ₹201.76 crore, down from ₹221.42 crore in Q3 FY25.9M FY26 Net Profit dropped to ₹13.96 crore from ₹38.28 crore in 9M FY25, a 63.5% decline.Finance costs for 9M FY26 decreased to ₹1.72 crore from ₹6.72 crore YoY due to debt repayment.Company has utilized ₹357.23 crore of IPO proceeds, with ₹181.56 crore spent on the Dhule plant expansion.
👀 கவனிக்க வேண்டியவை
While the sequential recovery in margins is encouraging, the significant year-on-year decline in 9M profitability warrants caution. Investors should monitor the impact of the Dhule plant expansion on future revenue growth.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
